Drug intelligence / Profile preview

gabapentin + vitamin b complex

Development stage
Phase 4
Lead developer
Merck KGaA
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Gabapentin + vitamin B complex** is a combination medication primarily used for the treatment of **neuropathic pain**, including painful diabetic neuropathy. The formulation usually contains gabapentin (an alpha-2 delta ligand that modulates calcium channels of nerve cells to decrease pain), and B-vitamins such as thiamine (B1) and cyanocobalamin or methylcobalamin (B12). The B vitamins contribute *neuroprotective* and *antiallodynic* effects, supporting nerve repair and reducing hyperalgesia. Combination therapy allows for lower gabapentin doses with similar efficacy and fewer adverse events such as dizziness and vertigo compared to gabapentin monotherapy. Mechanistically, gabapentin binds to the alpha-2 delta subunit of voltage-gated calcium channels, decreasing excitatory neurotransmitter release. B vitamins help regenerate damaged nerves and modulate neurotransmitter synthesis, serotonin, and GABA, attenuate glutamate, and act via the NO-cGMP pathway, hyperpolarizing nociceptor potassium channels and enhancing inhibitory control in the spinal cord[1][2][4][5][7].

Brand names
Gabantin PlusDoloneuronPentanerv MNurokind-GMNeuropillGabastar-MGabagesic MGabarich
Other names
gabapentin + methylcobalamingabapentin + mecobalamingabapentin + cyanocobalamingabapentin + B1/B12
02

Targets

CACNA2D2 (α2δ-2)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)

Beyond the preview

Go deeper on gabapentin + vitamin b complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gabapentin + vitamin b complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call